Lantheus Announces CEO Succession Plan
Lantheus Board Member and Pharmaceutical Industry Veteran Brian Markison Appointed Lantheus Chief Executive Officer, Effective March 1, 2024
Mary Anne Heino to Retire as Chief Executive Officer and Become Chair of the Board of Directors
Related news for (LNTH)
- Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
- Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
- Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
- Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference